Safety and Efficacy of VDPHL01 in Males and Females With AGA
Study sponsor: Veradermics, Inc. · MANE
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-08Estimated
Enrollment · participants70Estimated
Source updated2025-11-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.